• Martis Capital Makes Growth Investment in DCN Dx

    9 days ago - By San Diego Biotechnology

    New CEO joins lateral flow diagnostic developer's executive team
    CARLSBAD, Calif., Nov. 19, 2020 /PRNewswire/ - Martis Capital, a private equity firm focused on the healthcare industry, announced today a growth equity investment in DCN Dx, a lateral......
    Read more ...